Please login to the form below

Not currently logged in
Email:
Password:

licencing

This page shows the latest licencing news and features for those working in and with pharma, biotech and healthcare.

Chiesi's ultra-rare genetic disorder therapy wins European backing

Chiesi's ultra-rare genetic disorder therapy wins European backing

Europe.”. Lamzede, which has been investigated in 33 patients, both adults and children, and the Italian group expects a licencing decision by the European Commission in the second quarter of 2018.

Latest news

More from news
Approximately 1 fully matching, plus 5 partially matching documents found.

Latest appointments

  • Akari Therapeutics strengthens board Akari Therapeutics strengthens board

    Grissinger (pictured right) has spent 22 years at Johnson &Johnson, holding positions of vice president and head of worldwide pharmaceutical licencing, as well as vice president and head of worldwide pharmaceutical

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics